Skip to main content
    H

    Henry Schein Inc (HSIC)

    Official site

    HEALTHCARE • MEDICAL DISTRIBUTION • NASDAQ

    $84.96
    -1.26 (-1.46%)

    Market Cap: $9.53B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Henry Schein Inc (HSIC) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Henry Schein (HSIC) trades at 15.5x trailing earnings and 0.7x sales. Its P/E of 15.5x is below its 5-year median of 15.8x. Its forward P/E is 14.3x. The median P/E across 10 similar companies is 19.6x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 8.4% higher over the next year. Its free cash flow yield is 5.9%.

    MultipleValue
    P/E (trailing)15.5x
    Forward P/E14.3x
    Price to sales0.7x
    Price to book3.0x
    EV/EBITDA12.5x
    Price to FCF16.9x
    EV/FCF23.4x
    PEG1.7
    FCF yield5.9%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 9.4% below 17.1x, its P/S is 22.2% below 0.9x and its P/B is 3.2% below 3.1x.

    MultipleCurrent5-year median10-year median
    P/E15.5x15.8x17.1x
    P/S0.7x0.7x0.9x
    P/B3.0x2.7x3.1x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 14.6x in 2024 to 23.1x in 2020.

    Year endPriceP/EP/SP/B
    2025$75.5815.2x0.7x2.8x
    2024$69.2014.6x0.7x2.6x
    2023$75.7116.8x0.8x2.7x
    2022$79.8716.1x0.9x3.1x
    2021$77.5317.2x0.9x3.2x
    2020$66.8623.1x0.9x2.9x
    2019$66.7219.0x1.0x3.3x
    2018$78.5219.0x1.3x4.1x
    2017$69.8819.4x1.2x3.9x
    2016$75.8622.9x1.1x4.4x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HSIC

    What is HSIC's forward P/E ratio?

    Henry Schein has a forward P/E ratio of 14.3x.

    Is HSIC stock overvalued?

    GNG's valuation label for HSIC is Undervalued. Its P/E of 15.5x compares with a median of 19.6x across 10 similar companies.

    What is HSIC's price to sales ratio?

    Henry Schein has a price to sales ratio of 0.7x.

    What is Henry Schein's average P/E ratio over 5 years?

    Henry Schein's median P/E over the last 5 years is 15.8x, from 60 month-end values through Oct 2026.

    What is HSIC's PEG ratio?

    Henry Schein has a PEG ratio of 1.7.